APO Research
Talk to an analyst

APO RESEARCH · REPORT

Carbetocin for Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Carbetocin for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025192 pages

Choose your research edition.

Industry ResearchCarbetocin for Injection Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Carbetocin for Injection Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Carbetocin for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carbetocin for Injection Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Carbetocin for Injection Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Carbetocin for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Carbetocin for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Carbetocin for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Carbetocin for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Carbetocin for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Carbetocin for Injection include Abbott, Alembic Pharmaceuticals, Ferring Pharmaceuticals, Incepta Pharmaceuticals, PolyPeptide Laboratories, SGPharma, Taj Pharma, Cisen Pharmaceutical and Chengdu Leer Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Carbetocin for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Carbetocin for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Carbetocin for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Carbetocin for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Carbetocin for Injection Segment by Company

Abbott

Alembic Pharmaceuticals

Ferring Pharmaceuticals

Incepta Pharmaceuticals

PolyPeptide Laboratories

SGPharma

Taj Pharma

Cisen Pharmaceutical

Chengdu Leer Pharmaceutical

Chengdu Shengnuo Biotechnology

Hainan Zhonghe Pharmaceutical

Hybio Pharmaceutical

Hangzhou Ausia Biological Technology

Suzhou Erye Pharmaceutica

Suzhou Tianma Pharmaceutical

Xingyin Pharmaceutical

Carbetocin for Injection Segment by Type

Intravenous Injection

Intramuscular Injection

Carbetocin for Injection Segment by Application

Postpartum Hemorrhage

Uterine Atony

Other

Carbetocin for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carbetocin for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carbetocin for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carbetocin for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Carbetocin for Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Carbetocin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Carbetocin for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Carbetocin for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Carbetocin for Injection Industry Trends Table 2. Carbetocin for Injection Industry Drivers Table 3. Carbetocin for Injection Industry Opportunities and Challenges Table 4. Carbetocin for Injection Industry Restraints Table 5. Global Carbetocin for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Carbetocin for Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Carbetocin for Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Carbetocin for Injection Sales Market Share by Manufacturers Table 9. Global Carbetocin for Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Carbetocin for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Carbetocin for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Carbetocin for Injection Manufacturers, Product Type & Application Table 13. Global Carbetocin for Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Carbetocin for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Intravenous Injection Table 17. Major Manufacturers of Intramuscular Injection Table 18. Global Carbetocin for Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Carbetocin for Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Carbetocin for Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Carbetocin for Injection Sales Market Share by Type (2021-2026) Table 22. Global Carbetocin for Injection Sales Market Share by Type (2027-2032) Table 23. Global Carbetocin for Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Carbetocin for Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Carbetocin for Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Carbetocin for Injection Revenue Market Share by Type (2021-2026) Table 27. Global Carbetocin for Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Postpartum Hemorrhage Table 29. Major Manufacturers of Uterine Atony Table 30. Major Manufacturers of Other Table 31. Global Carbetocin for Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Carbetocin for Injection Sales by Application (2021-2026) & (K Units) Table 33. Global Carbetocin for Injection Sales by Application (2027-2032) & (K Units) Table 34. Global Carbetocin for Injection Sales Market Share by Application (2021-2026) Table 35. Global Carbetocin for Injection Sales Market Share by Application (2027-2032) Table 36. Global Carbetocin for Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Carbetocin for Injection Revenue by Application (2021-2026) & (K Units) Table 38. Global Carbetocin for Injection Revenue by Application (2027-2032) & (K Units) Table 39. Global Carbetocin for Injection Revenue Market Share by Application (2021-2026) Table 40. Global Carbetocin for Injection Revenue Market Share by Application (2027-2032) Table 41. Global Carbetocin for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Carbetocin for Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Carbetocin for Injection Sales Market Share by Region (2021-2026) Table 44. Global Carbetocin for Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Carbetocin for Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Carbetocin for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Carbetocin for Injection Sales by Country (2021-2026) & (K Units) Table 48. North America Carbetocin for Injection Sales by Country (2027-2032) & (K Units) Table 49. Europe Carbetocin for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Carbetocin for Injection Sales by Country (2021-2026) & (K Units) Table 51. Europe Carbetocin for Injection Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Carbetocin for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Carbetocin for Injection Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Carbetocin for Injection Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Carbetocin for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Carbetocin for Injection Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Carbetocin for Injection Sales by Country (2027-2032) & (K Units) Table 58. Global Carbetocin for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Carbetocin for Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Carbetocin for Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Carbetocin for Injection Revenue Market Share by Region (2021-2026) Table 62. Global Carbetocin for Injection Revenue Market Share by Region (2027-2032) Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Abbott Carbetocin for Injection Product Portfolio Table 67. Abbott Recent Development Table 68. Alembic Pharmaceuticals Company Information Table 69. Alembic Pharmaceuticals Business Overview Table 70. Alembic Pharmaceuticals Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Alembic Pharmaceuticals Carbetocin for Injection Product Portfolio Table 72. Alembic Pharmaceuticals Recent Development Table 73. Ferring Pharmaceuticals Company Information Table 74. Ferring Pharmaceuticals Business Overview Table 75. Ferring Pharmaceuticals Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Ferring Pharmaceuticals Carbetocin for Injection Product Portfolio Table 77. Ferring Pharmaceuticals Recent Development Table 78. Incepta Pharmaceuticals Company Information Table 79. Incepta Pharmaceuticals Business Overview Table 80. Incepta Pharmaceuticals Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Incepta Pharmaceuticals Carbetocin for Injection Product Portfolio Table 82. Incepta Pharmaceuticals Recent Development Table 83. PolyPeptide Laboratories Company Information Table 84. PolyPeptide Laboratories Business Overview Table 85. PolyPeptide Laboratories Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. PolyPeptide Laboratories Carbetocin for Injection Product Portfolio Table 87. PolyPeptide Laboratories Recent Development Table 88. SGPharma Company Information Table 89. SGPharma Business Overview Table 90. SGPharma Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. SGPharma Carbetocin for Injection Product Portfolio Table 92. SGPharma Recent Development Table 93. Taj Pharma Company Information Table 94. Taj Pharma Business Overview Table 95. Taj Pharma Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Taj Pharma Carbetocin for Injection Product Portfolio Table 97. Taj Pharma Recent Development Table 98. Cisen Pharmaceutical Company Information Table 99. Cisen Pharmaceutical Business Overview Table 100. Cisen Pharmaceutical Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Cisen Pharmaceutical Carbetocin for Injection Product Portfolio Table 102. Cisen Pharmaceutical Recent Development Table 103. Chengdu Leer Pharmaceutical Company Information Table 104. Chengdu Leer Pharmaceutical Business Overview Table 105. Chengdu Leer Pharmaceutical Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Chengdu Leer Pharmaceutical Carbetocin for Injection Product Portfolio Table 107. Chengdu Leer Pharmaceutical Recent Development Table 108. Chengdu Shengnuo Biotechnology Company Information Table 109. Chengdu Shengnuo Biotechnology Business Overview Table 110. Chengdu Shengnuo Biotechnology Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Chengdu Shengnuo Biotechnology Carbetocin for Injection Product Portfolio Table 112. Chengdu Shengnuo Biotechnology Recent Development Table 113. Hainan Zhonghe Pharmaceutical Company Information Table 114. Hainan Zhonghe Pharmaceutical Business Overview Table 115. Hainan Zhonghe Pharmaceutical Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Hainan Zhonghe Pharmaceutical Carbetocin for Injection Product Portfolio Table 117. Hainan Zhonghe Pharmaceutical Recent Development Table 118. Hybio Pharmaceutical Company Information Table 119. Hybio Pharmaceutical Business Overview Table 120. Hybio Pharmaceutical Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Hybio Pharmaceutical Carbetocin for Injection Product Portfolio Table 122. Hybio Pharmaceutical Recent Development Table 123. Hangzhou Ausia Biological Technology Company Information Table 124. Hangzhou Ausia Biological Technology Business Overview Table 125. Hangzhou Ausia Biological Technology Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Hangzhou Ausia Biological Technology Carbetocin for Injection Product Portfolio Table 127. Hangzhou Ausia Biological Technology Recent Development Table 128. Suzhou Erye Pharmaceutica Company Information Table 129. Suzhou Erye Pharmaceutica Business Overview Table 130. Suzhou Erye Pharmaceutica Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Suzhou Erye Pharmaceutica Carbetocin for Injection Product Portfolio Table 132. Suzhou Erye Pharmaceutica Recent Development Table 133. Suzhou Tianma Pharmaceutical Company Information Table 134. Suzhou Tianma Pharmaceutical Business Overview Table 135. Suzhou Tianma Pharmaceutical Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Suzhou Tianma Pharmaceutical Carbetocin for Injection Product Portfolio Table 137. Suzhou Tianma Pharmaceutical Recent Development Table 138. Xingyin Pharmaceutical Company Information Table 139. Xingyin Pharmaceutical Business Overview Table 140. Xingyin Pharmaceutical Carbetocin for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Xingyin Pharmaceutical Carbetocin for Injection Product Portfolio Table 142. Xingyin Pharmaceutical Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Carbetocin for Injection Distributors List Table 146. Carbetocin for Injection Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Carbetocin for Injection Product Image Figure 2. Global Carbetocin for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carbetocin for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Carbetocin for Injection Sales (2021-2032) & (K Units) Figure 5. Global Carbetocin for Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Carbetocin for Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Intravenous Injection Image Figure 9. Intramuscular Injection Image Figure 10. Global Carbetocin for Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Carbetocin for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Carbetocin for Injection Sales Market Share by Type (2021-2032) Figure 13. Global Carbetocin for Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Carbetocin for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Carbetocin for Injection Revenue Market Share by Type (2021-2032) Figure 16. Postpartum Hemorrhage Image Figure 17. Uterine Atony Image Figure 18. Other Image Figure 19. Global Carbetocin for Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Carbetocin for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Carbetocin for Injection Sales Market Share by Application (2021-2032) Figure 22. Global Carbetocin for Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Carbetocin for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Carbetocin for Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Carbetocin for Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Carbetocin for Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Carbetocin for Injection Sales Market Share by Country (2021-2032) Figure 39. China Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Carbetocin for Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Carbetocin for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Carbetocin for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Carbetocin for Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Carbetocin for Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Carbetocin for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Carbetocin for Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Carbetocin for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Carbetocin for Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Carbetocin for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Carbetocin for Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Carbetocin for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Carbetocin for Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Carbetocin for Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous Injection
  • Intramuscular Injection
Applications
  • Postpartum Hemorrhage
  • Uterine Atony
  • Other
Companies covered
  • Abbott
  • Alembic Pharmaceuticals
  • Ferring Pharmaceuticals
  • Incepta Pharmaceuticals
  • PolyPeptide Laboratories
  • SGPharma
  • Taj Pharma
  • Cisen Pharmaceutical
  • Chengdu Leer Pharmaceutical
  • Chengdu Shengnuo Biotechnology
  • Hainan Zhonghe Pharmaceutical
  • Hybio Pharmaceutical
  • Hangzhou Ausia Biological Technology
  • Suzhou Erye Pharmaceutica
  • Suzhou Tianma Pharmaceutical
  • Xingyin Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Carbetocin for Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Carbetocin for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Carbetocin for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Carbetocin for Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Carbetocin for Injection Market Dynamics
  1. 2.1 Carbetocin for Injection Industry Trends
  2. 2.2 Carbetocin for Injection Industry Drivers
  3. 2.3 Carbetocin for Injection Industry Opportunities and Challenges
  4. 2.4 Carbetocin for Injection Industry Restraints
3 Carbetocin for Injection Market by Manufacturers
  1. 3.1 Global Carbetocin for Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Carbetocin for Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Carbetocin for Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Carbetocin for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Carbetocin for Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Carbetocin for Injection Manufacturers, Product Type & Application
  7. 3.7 Global Carbetocin for Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Carbetocin for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Carbetocin for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Carbetocin for Injection Tier 1, Tier 2, and Tier 3
4 Carbetocin for Injection Market by Type
  1. 4.1 Carbetocin for Injection Type Introduction
  2. 4.1.1 Intravenous Injection
  3. 4.1.2 Intramuscular Injection
  4. 4.2 Global Carbetocin for Injection Sales by Type
  5. 4.2.1 Global Carbetocin for Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Carbetocin for Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Carbetocin for Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Carbetocin for Injection Revenue by Type
  9. 4.3.1 Global Carbetocin for Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Carbetocin for Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Carbetocin for Injection Revenue Market Share by Type (2021-2032)
5 Carbetocin for Injection Market by Application
  1. 5.1 Carbetocin for Injection Application Introduction
  2. 5.1.1 Postpartum Hemorrhage
  3. 5.1.2 Uterine Atony
  4. 5.1.3 Other
  5. 5.2 Global Carbetocin for Injection Sales by Application
  6. 5.2.1 Global Carbetocin for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Carbetocin for Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Carbetocin for Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Carbetocin for Injection Revenue by Application
  10. 5.3.1 Global Carbetocin for Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Carbetocin for Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Carbetocin for Injection Revenue Market Share by Application (2021-2032)
6 Global Carbetocin for Injection Sales by Region
  1. 6.1 Global Carbetocin for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Carbetocin for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Carbetocin for Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Carbetocin for Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Carbetocin for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Carbetocin for Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Carbetocin for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Carbetocin for Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Carbetocin for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Carbetocin for Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Carbetocin for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Carbetocin for Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Carbetocin for Injection Revenue by Region
  1. 7.1 Global Carbetocin for Injection Revenue by Region
  2. 7.1.1 Global Carbetocin for Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Carbetocin for Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Carbetocin for Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Carbetocin for Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Carbetocin for Injection Revenue (2021-2032)
  8. 7.2.2 North America Carbetocin for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Carbetocin for Injection Revenue (2021-2032)
  11. 7.3.2 Europe Carbetocin for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Carbetocin for Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Carbetocin for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Carbetocin for Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Carbetocin for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Carbetocin for Injection Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Alembic Pharmaceuticals
  8. 8.2.1 Alembic Pharmaceuticals Company Information
  9. 8.2.2 Alembic Pharmaceuticals Business Overview
  10. 8.2.3 Alembic Pharmaceuticals Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Alembic Pharmaceuticals Carbetocin for Injection Product Portfolio
  12. 8.2.5 Alembic Pharmaceuticals Recent Developments
  13. 8.3 Ferring Pharmaceuticals
  14. 8.3.1 Ferring Pharmaceuticals Company Information
  15. 8.3.2 Ferring Pharmaceuticals Business Overview
  16. 8.3.3 Ferring Pharmaceuticals Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ferring Pharmaceuticals Carbetocin for Injection Product Portfolio
  18. 8.3.5 Ferring Pharmaceuticals Recent Developments
  19. 8.4 Incepta Pharmaceuticals
  20. 8.4.1 Incepta Pharmaceuticals Company Information
  21. 8.4.2 Incepta Pharmaceuticals Business Overview
  22. 8.4.3 Incepta Pharmaceuticals Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Incepta Pharmaceuticals Carbetocin for Injection Product Portfolio
  24. 8.4.5 Incepta Pharmaceuticals Recent Developments
  25. 8.5 PolyPeptide Laboratories
  26. 8.5.1 PolyPeptide Laboratories Company Information
  27. 8.5.2 PolyPeptide Laboratories Business Overview
  28. 8.5.3 PolyPeptide Laboratories Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PolyPeptide Laboratories Carbetocin for Injection Product Portfolio
  30. 8.5.5 PolyPeptide Laboratories Recent Developments
  31. 8.6 SGPharma
  32. 8.6.1 SGPharma Company Information
  33. 8.6.2 SGPharma Business Overview
  34. 8.6.3 SGPharma Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SGPharma Carbetocin for Injection Product Portfolio
  36. 8.6.5 SGPharma Recent Developments
  37. 8.7 Taj Pharma
  38. 8.7.1 Taj Pharma Company Information
  39. 8.7.2 Taj Pharma Business Overview
  40. 8.7.3 Taj Pharma Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Taj Pharma Carbetocin for Injection Product Portfolio
  42. 8.7.5 Taj Pharma Recent Developments
  43. 8.8 Cisen Pharmaceutical
  44. 8.8.1 Cisen Pharmaceutical Company Information
  45. 8.8.2 Cisen Pharmaceutical Business Overview
  46. 8.8.3 Cisen Pharmaceutical Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cisen Pharmaceutical Carbetocin for Injection Product Portfolio
  48. 8.8.5 Cisen Pharmaceutical Recent Developments
  49. 8.9 Chengdu Leer Pharmaceutical
  50. 8.9.1 Chengdu Leer Pharmaceutical Company Information
  51. 8.9.2 Chengdu Leer Pharmaceutical Business Overview
  52. 8.9.3 Chengdu Leer Pharmaceutical Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Chengdu Leer Pharmaceutical Carbetocin for Injection Product Portfolio
  54. 8.9.5 Chengdu Leer Pharmaceutical Recent Developments
  55. 8.10 Chengdu Shengnuo Biotechnology
  56. 8.10.1 Chengdu Shengnuo Biotechnology Company Information
  57. 8.10.2 Chengdu Shengnuo Biotechnology Business Overview
  58. 8.10.3 Chengdu Shengnuo Biotechnology Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Chengdu Shengnuo Biotechnology Carbetocin for Injection Product Portfolio
  60. 8.10.5 Chengdu Shengnuo Biotechnology Recent Developments
  61. 8.11 Hainan Zhonghe Pharmaceutical
  62. 8.11.1 Hainan Zhonghe Pharmaceutical Company Information
  63. 8.11.2 Hainan Zhonghe Pharmaceutical Business Overview
  64. 8.11.3 Hainan Zhonghe Pharmaceutical Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hainan Zhonghe Pharmaceutical Carbetocin for Injection Product Portfolio
  66. 8.11.5 Hainan Zhonghe Pharmaceutical Recent Developments
  67. 8.12 Hybio Pharmaceutical
  68. 8.12.1 Hybio Pharmaceutical Company Information
  69. 8.12.2 Hybio Pharmaceutical Business Overview
  70. 8.12.3 Hybio Pharmaceutical Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hybio Pharmaceutical Carbetocin for Injection Product Portfolio
  72. 8.12.5 Hybio Pharmaceutical Recent Developments
  73. 8.13 Hangzhou Ausia Biological Technology
  74. 8.13.1 Hangzhou Ausia Biological Technology Company Information
  75. 8.13.2 Hangzhou Ausia Biological Technology Business Overview
  76. 8.13.3 Hangzhou Ausia Biological Technology Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hangzhou Ausia Biological Technology Carbetocin for Injection Product Portfolio
  78. 8.13.5 Hangzhou Ausia Biological Technology Recent Developments
  79. 8.14 Suzhou Erye Pharmaceutica
  80. 8.14.1 Suzhou Erye Pharmaceutica Company Information
  81. 8.14.2 Suzhou Erye Pharmaceutica Business Overview
  82. 8.14.3 Suzhou Erye Pharmaceutica Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Suzhou Erye Pharmaceutica Carbetocin for Injection Product Portfolio
  84. 8.14.5 Suzhou Erye Pharmaceutica Recent Developments
  85. 8.15 Suzhou Tianma Pharmaceutical
  86. 8.15.1 Suzhou Tianma Pharmaceutical Company Information
  87. 8.15.2 Suzhou Tianma Pharmaceutical Business Overview
  88. 8.15.3 Suzhou Tianma Pharmaceutical Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Suzhou Tianma Pharmaceutical Carbetocin for Injection Product Portfolio
  90. 8.15.5 Suzhou Tianma Pharmaceutical Recent Developments
  91. 8.16 Xingyin Pharmaceutical
  92. 8.16.1 Xingyin Pharmaceutical Company Information
  93. 8.16.2 Xingyin Pharmaceutical Business Overview
  94. 8.16.3 Xingyin Pharmaceutical Carbetocin for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Xingyin Pharmaceutical Carbetocin for Injection Product Portfolio
  96. 8.16.5 Xingyin Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Carbetocin for Injection Value Chain Analysis
  2. 9.1.1 Carbetocin for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Carbetocin for Injection Production Mode & Process
  6. 9.2 Carbetocin for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Carbetocin for Injection Distributors
  9. 9.2.3 Carbetocin for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst